Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Therapeutic Protein Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Therapeutic Protein Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Therapeutic Protein Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Therapeutic Protein Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 01 Jul 2021
  • Report ID: HLT 00231
  • Pages: 181
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

According to a study published by Insure Insights, the global therapeutic protein market is estimated to grow at a CAGR of 9.6% during the forecast period. Therapeutic proteins are the developed proteins in the laboratory intended for pharmaceutical use. Recombinant DNA technology makes it easy to make proteins in particular host cells such as bacteria, yeast, or mammalian cells under optimum conditions. The host for production chosen depends on the protein required. Mammalian cells are the most favored host cell as their posttranslational modifications like glycosylation and sialylation significantly impact the protein’s pharmacokinetics and protein’s efficiency. Therapeutic proteins help in the personalized medicine concept. They make it easy for the individualized treatment by associating with the specifically targeted therapeutic procedure by recompensing the deficiency of the deficient protein.

Top Driver: Introduction & Adoption of New Plasma-Derived Therapies and Rising in the Prevalence of Chronic Disorders

The major factors that propel the growth of the global protein therapeutics market are the introduction & adoption of new plasma-derived therapies, rising in the prevalence of chronic & life-threatening diseases, and growing awareness among the populace concerning the high efficiency of protein therapeutics. On the other hand, the high cost of protein therapies and complex reimbursement scenarios hinder market growth. Conversely, introduction in novel indications for known protein therapeutics and untapped emerging markets are expected to create lucrative opportunities for the manufacturers in this industry.

Cancer Segment is Estimated to Witness Significant Growth During the Forecast Period

The global therapeutic protein market has been segmented into cancer, infectious disease, hemophilia, and others on the basis of indications. Among these, cancer segment is estimated to holds the largest market share and is expected to continue the trend during the forecast period. The growth is attributed to increasing incidences of cancer across the world. On the basis of therapeutic protein type, the market is segmented into monoclonal antibodies, erythropoietin, insulin, interferon, and others. On the end-user, the market is segmented into pharmaceutical companies, healthcare service providers, research organizations, and others.

   Emerging Market Players in the Untapped Region and Rising R&D Activities to Benefit Asia Pacific Market

Asia-Pacific is expected to be the fastest-growing regional market. The growth is attributed to the emerging market players in the untapped region, rising R&D activities in the protein therapeutics segment, growing focus of government toward vaccination to prevent various diseases, and massive target population. For instance, the Japanese government has been offering free hepatitis testing since 2002 for all citizens aged between 40 and 70 years of age as part of routine health check-up. The rising geriatric population is one of the significant factors propelling market growth in the region.

Players to Focus on Research and Development

The global therapeutic market is estimated to stay fragmented during the forecast period owing to the possible new entrants. The major market players operating in the market include Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer Inc., and Sanofi. Other players (profiles not included in the report) in the value chain analysis include Biogen, Inc., CSL Behring, and Genentech, Inc.

Baxter International Inc.: In September 2020, Baxter International Inc., a global leader in clinical nutrition received the U.S. Food and Drug Administration (FDA) approval of new formulations of Clinimix Injections and Clinimix E Injections. The Clinimix formulations contain up to 80 g/L of amino acids, the highest protein in any multi-chamber bag available in the U.S., making it easier to reach patient protein targets while delivering less fluid and dextrose than provided by existing formulations.

Scope of the Report

By Indication

  • Cancer
  • Hemophilia
  • Infectious disease
  • Others

By Therapeutic Protein  

  • Monoclonal Antibodies
  • Interferon
  • Erythropoietin
  • Insulin
  • Others

By End-Users  

  • Pharmaceutical companies
  • Healthcare service providers
  • Research Organizations
  • Academic Research Institutes

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report